AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2023 Issue 1; Section X - New Technology

Transfusion of New Therapeutic Substances

In Section X, New Technology, table XW1, Transfusion of Anatomical Regions, New Technology value J Exagamglogene Autotemcel was added to body parts 3 Peripheral Vein and 4 Central Vein, to capture the intravenous administration of exagamglogene autotemcel (exa-cel), an autologous ex vivo gene-edited biological product that is used to increase fetal hemoglobin (HbF) in patients with transfusion-dependent beta thalassemia (TDT) and severe sickle cell disease (SCD). HbF is a fetal form of oxygen-carrying hemoglobin that decreases during infancy but transports oxygen more efficiently than adult hemoglobin.First, the patient’s hematopoietic stem cells are harvested from the blood. Exa-cel...

To read the full article, sign in and subscribe to AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS .

Thank you for choosing Find-A-Code, please Sign In to remove ads.